These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33383877)

  • 21. HCV-infected solid organ donors, direct-acting antivirals and the current challenges.
    Fabrizi F; Cerutti R; Silva M
    Expert Rev Clin Pharmacol; 2020 Jan; 13(1):7-14. PubMed ID: 31786966
    [No Abstract]   [Full Text] [Related]  

  • 22. Pros and Cons: Usage of organs from donors infected with hepatitis C virus - Revision in the direct-acting antiviral era.
    Coilly A; Samuel D
    J Hepatol; 2016 Jan; 64(1):226-31. PubMed ID: 26375245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection.
    Xue Y; Zhang LX; Wang L; Li T; Qu YD; Liu F
    World J Gastroenterol; 2017 Aug; 23(32):5969-5976. PubMed ID: 28932089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.
    Dao A; Cuffy M; Kaiser TE; Loethen A; Cafardi J; Luckett K; Rike AH; Cardi M; Alloway RR; Govil A; Diwan T; Sherman KE; Shah SA; Woodle ES
    Clin Transplant; 2019 Jul; 33(7):e13598. PubMed ID: 31104346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Novel antiviral agents for the treatment of HCV among renal transplant recipients].
    Fabrizi F; Donato FM; Messa P
    G Ital Nefrol; 2017 Aug; 34(4):35-50. PubMed ID: 28762681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart Transplantation for Hepatitis C Virus Non-Viremic Recipients From Hepatitis C Virus Viremic Donors.
    Frager SZ; Dhand A; Gass A; Levine A; Spielvogel D; Nog R; Wolf DC; Bodin RI
    Cardiol Rev; 2019; 27(4):179-181. PubMed ID: 31180937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-Center Experience in Pre-transplant Hepatitis C Virus (HCV) Treatment Among Living Donor Liver Transplant Candidates: Bridging the Direct-Acting Antivirals (DAA).
    Niranjan-Azadi AM; Kabacam G; Durand CM; Anjum S; Saberi B; Dagher NN; Philosophe B; Gurakar A
    Ann Transplant; 2017 Sep; 22():570-574. PubMed ID: 28935852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C: Current Controversies and Future Potential in Solid Organ Transplantation.
    Somerville L; Doucette K
    Curr Infect Dis Rep; 2018 May; 20(7):18. PubMed ID: 29789956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys.
    Potluri VS; Goldberg DS; Mohan S; Bloom RD; Sawinski D; Abt PL; Blumberg EA; Parikh CR; Sharpe J; Reddy KR; Molnar MZ; Sise M; Reese PP
    J Am Soc Nephrol; 2019 Oct; 30(10):1939-1951. PubMed ID: 31515244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of kidney donor hepatitis C virus serostatus on renal transplant recipient and allograft outcomes.
    Cohen JB; Eddinger KC; Shelton B; Locke JE; Forde KA; Sawinski D
    Clin Kidney J; 2017 Aug; 10(4):564-572. PubMed ID: 28852496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accepting hepatitis C virus-infected donor hearts for transplantation: Multistep consent, unrealized opportunity, and the Stanford experience.
    Moayedi Y; Gulamhusein AF; Ross HJ; Teuteberg JJ; Khush KK
    Clin Transplant; 2018 Jul; 32(7):e13308. PubMed ID: 29869354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.
    Sawinski D; Forde KA; Lo Re V; Goldberg DS; Cohen JB; Locke JE; Bloom RD; Brensinger C; Weldon J; Shults J; Reese PP
    Am J Kidney Dis; 2019 Jun; 73(6):815-826. PubMed ID: 30704882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Timing of hepatitis C virus infection treatment in kidney transplant candidates.
    Cohen-Bucay A; Francis JM; Gordon CE
    Hemodial Int; 2018 Apr; 22 Suppl 1():S61-S70. PubMed ID: 29694723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.
    Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
    Liver Transpl; 2019 Apr; 25(4):598-609. PubMed ID: 30716208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful Management of Graft Reinfection of HCV Genotype 2 in Living Donor Liver Transplantation from a Hepatitis B Core Antibody-Positive Donor with Sofosbuvir and Ribavirin.
    Sasaki R; Kanda T; Ohtsuka M; Yasui S; Haga Y; Nakamura M; Yokoyama M; Wu S; Nakamoto S; Arai M; Maruyama H; Miyazaki M; Yokosuka O
    Case Rep Gastroenterol; 2016; 10(2):366-372. PubMed ID: 27721720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient.
    Campos-Varela I; Agudelo EZ; Sarkar M; Roberts JP; Terrault NA
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29125670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens.
    Shah AP; Cameron A; Singh P; Frank AM; Fenkel JM
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28060446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients.
    Luckett K; Kaiser TE; Bari K; Safdar K; Schoech MR; Apewokin S; Diwan TS; Cuffy MC; Anwar N; Shah SA
    J Am Coll Surg; 2019 Apr; 228(4):560-567. PubMed ID: 30586641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients.
    Sise ME; Chute DF; Gustafson JL; Wojciechowski D; Elias N; Chung RT; Williams WW
    Hemodial Int; 2018 Apr; 22 Suppl 1():S71-S80. PubMed ID: 29694722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Provider Attitudes toward the Use of Hepatitis C Virus-Positive Organs in Kidney Transplantation.
    Couri T; Katz J; Stoeckle K; Nugooru A; Yeh H; Chung R; Paul S
    Am J Nephrol; 2019; 50(3):168-176. PubMed ID: 31390615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.